These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 32972546)

  • 61. Cardiac amyloidosis: a significant blind spot of the H2FPEF score.
    Duca F; Rettl R; Binder C; Dusik F; Schrutka L; Dalos D; Öztürk B; Capelle CD; Qin H; Dachs TM; Camuz Ligios L; Agis H; Kain R; Hengstenberg C; Badr-Eslam R; Kastner J; Bonderman D
    Panminerva Med; 2023 Dec; 65(4):491-498. PubMed ID: 36789997
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
    Paton DM
    Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy of Computed Tomography-Based Evaluation of Myocardial Extracellular Volume Combined With Red Flags for Early Screening of Concealed Cardiac Amyloidosis in Patients With Atrial Fibrillation.
    Yamasaki H; Kondo H; Shiroo T; Iwata N; Masuda T; Makita T; Iwabuchi Y; Tanazawa K; Takahashi M; Ono Y; Ogawa N; Harada T; Mitarai K; Yamauchi S; Takano M; Kodama N; Hirota K; Miyoshi M; Yonezu K; Tawara K; Abe I; Saito S; Fukui A; Fukuda T; Akioka H; Shinohara T; Akiyoshi K; Teshima Y; Yufu K; Daa T; Matsubara E; Asayama Y; Ueda M; Takahashi N
    Circ J; 2024 Jun; 88(7):1167-1175. PubMed ID: 38522901
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).
    Phull P; Sanchorawala V; Connors LH; Doros G; Ruberg FL; Berk JL; Sarosiek S
    Amyloid; 2018 Mar; 25(1):62-67. PubMed ID: 29424556
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relation of Body Mass Index to Transthyretin Cardiac Amyloidosis Particularly in Black and Hispanic Patients (from the SCAN-MP Study).
    Poterucha TJ; Kurian D; Raiszadeh F; Teruya S; Elias P; Kogan R; Chiuzan C; Einstein AJ; Ruberg FL; Maurer MS
    Am J Cardiol; 2022 Aug; 177():116-120. PubMed ID: 35705430
    [TBL] [Abstract][Full Text] [Related]  

  • 66. When and how do patients with cardiac amyloidosis die?
    Escher F; Senoner M; Doerler J; Zaruba MM; Messner M; Mussner-Seeber C; Ebert M; Ensinger C; Mair A; Kroiss A; Ulmer H; Schneiderbauer-Porod S; Ebner C; Poelzl G
    Clin Res Cardiol; 2020 Jan; 109(1):78-88. PubMed ID: 31134330
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors.
    Barge-Caballero G; Vázquez-García R; Barge-Caballero E; Couto-Mallón D; Paniagua-Martín MJ; Barriales-Villa R; Piñón-Esteban P; Bouzas-Mosquera A; Pombo-Otero J; Debén-Ariznavarreta G; Vázquez-Rodríguez JM; Crespo-Leiro MG
    Med Clin (Barc); 2021 Apr; 156(8):369-378. PubMed ID: 32591181
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?
    Rubin J; Alvarez J; Teruya S; Castano A; Lehman RA; Weidenbaum M; Geller JA; Helmke S; Maurer MS
    Amyloid; 2017 Dec; 24(4):226-230. PubMed ID: 28906148
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of the Cox-maze procedure for atrial fibrillation concomitant to mitral and tricuspid valve surgery.
    Ad N; Holmes SD; Massimiano PS; Pritchard G; Stone LE; Henry L
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1426-34; discussion 1434-5. PubMed ID: 24075462
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Epidemiology and therapy of atrial fibrillation].
    Capucci A; Aschieri D; Villani GQ
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis.
    Tan NY; Mohsin Y; Hodge DO; Lacy MQ; Packer DL; Dispenzieri A; Grogan M; Asirvatham SJ; Madhavan M; McLEOD CJ
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1167-1173. PubMed ID: 27422772
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies.
    Milandri A; Farioli A; Gagliardi C; Longhi S; Salvi F; Curti S; Foffi S; Caponetti AG; Lorenzini M; Ferlini A; Rimessi P; Mattioli S; Violante FS; Rapezzi C
    Eur J Heart Fail; 2020 Mar; 22(3):507-515. PubMed ID: 31975495
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
    Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
    Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical and prognostic significance of central and obstructive apneas in patients with transthyretin cardiac amyloidosis.
    Gentile F; Giannoni A; Aimo A; Castiglione V; Bramanti F; Iudice G; Degl'Innocenti E; Emdin M; Vergaro G; Passino C
    Eur J Prev Cardiol; 2024 Sep; ():. PubMed ID: 39308231
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Atrial Tachyarrhythmias Among Patients With Left Ventricular Assist Devices: Prevalence, Clinical Outcomes, and Impact of Rhythm Control Strategies.
    Noll AE; Adewumi J; Amuthan R; Gillombardo CB; Mannan Z; Kiehl EL; Hussein AA; Chung MK; Wazni OM; Starling RC; Soltesz EG; Cantillon DJ
    JACC Clin Electrophysiol; 2019 Apr; 5(4):459-466. PubMed ID: 31000099
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differential recovery of regional atrial contraction after restoration of sinus rhythm after intraoperative linear radiofrequency ablation for atrial fibrillation.
    Boyd AC; Schiller NB; Ross DL; Thomas L
    Am J Cardiol; 2009 Feb; 103(4):528-34. PubMed ID: 19195515
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Impact of Elevated Left Atrial Pressure in Sinus Rhythm After Cardioversion on Outcomes After Catheter Ablation for Atrial Fibrillation.
    Kishima H; Mine T; Takahashi S; Ashida K; Ishihara M; Masuyama T
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):813-9. PubMed ID: 27090869
    [TBL] [Abstract][Full Text] [Related]  

  • 80. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
    Blackshear JL; Safford RE; ;
    Card Electrophysiol Rev; 2003 Dec; 7(4):366-9. PubMed ID: 15071255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.